Dova Pharmaceuticals Inc.
DelistedCIK 1685071fmd_0N98B21PQPBCGSWPXDRYEGH60MManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 02, 2016 to Sep 30, 2019, 14 periods
| Line item | FY2017 | FY2018 |
|---|---|---|
| Total revenues | 0 | 10 |
| Cost of revenue | 0 | 1 |
| Gross profit | 0 | 9 |
| Research and development | 16 | 18 |
| Selling, general and administrative | 13 | 62 |
| Total operating expenses | 29 | 81 |
| Operating income | (29) | (71) |
| Interest expense | 1 | 2 |
| Other non-operating income (expense) | 0 | 1 |
| Net income | (30) | (72) |